Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma

NCT01029054

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Mt. Sinai Medical Center New York, United States
View Trial Details
Completed

Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone

NCT01237249

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • H. Son Llatzer Palma de Mallorca, Balearic Islands, Spain
  • H. Vall d'Hebron, Barcelona Barcelona, Spain
  • ICO - Duran i Reynals, Hospitalet de Llobregat Barcelona, Spain
  • Hospital General de Castellón Castellon, Castellón, Spain
View all 63 locations
View Trial Details
Completed

National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions

NCT01322165

Conditions
Abnormalities, Multiple, Aneurysm, Aortic Aneurysm, +54 more
Locations
  • Queens Medical Center Honolulu, Hawaii, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • The New York Presbyterian Hospital-Weill Cornell Medical Center New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Completed

Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

NCT00002779

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
View all 20 locations
View Trial Details

Related conditions